Deals
Deal to spur better 911 call locating for U.S. cellphone users
Emergency responders will be able to better locate callers who dial 911 on their cellphones from indoors as the U.S. wireless industry improves caller-location for the majority of such calls over the next six years.
ContraFect Corporation Announces Third Quarter 2014 Results
ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant infectious diseases, today announced results for the third quarter ended September 30, 2014. The Company closed its initial public offering (IPO) on August 1, 2014.
Aumento Capital V Corporation Announces Closing of Initial Public Offering
Aumento Capital V Corporation (the "Corporation"), is pleased to announce that it has completed its initial public offering (the "Offering") today of 1,015,000 Common Shares at a purchase price of $0.60 per Common Share by way of a prospectus for gross proceeds of $609,000.
Geron sells last drug in pipeline to J&J unit
Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.